ALS Investment Fund invests in biotechnology companies that develop drugs and diagnostics for the treatment of Lou Gehrig's disease.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
ALS Investment Fund invests in biotechnology companies that develop drugs and diagnostics for the treatment of Lou Gehrig's disease.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2017 | Orphazyme | Venture Round | 0 |
6/2018 | Emulate | Series C | 36M |
11/2021 | Prilenia | Series B | 0 |
8/2016 | Amylyx Pharmaceuticals | Series A | 0 |
1/2019 | Apic Bio | Series A | 0 |
12/2021 | Bloom Science | Series A | 12M |
3/2023 | QurAlis | Series B | 0 |
12/2021 | Verge Genomics | Series B | 98M |
7/2018 | Verge Genomics | Series A | 0 |
12/2021 | Verge Genomics | Series B | 0 |
12/2021 | Bloom Science | Series A | 0 |
11/2021 | Prilenia | Series B | 0 |
1/2019 | Apic Bio | Series A | 0 |
7/2018 | Verge Genomics | Series A | 0 |
6/2018 | Emulate | Series C | 0 |
3/2017 | Orphazyme | Venture Round | 0 |
8/2016 | Amylyx Pharmaceuticals | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|